mediwound.com (MDWD) Forward Price-to-Revenue Multiple

Corporate company logo of MediWound Ltd (MDWD)

The forward P/S dynamics reflect the market valuation of MediWound Ltd. (MDWD), where the 16.70 metric indicates the asset's status. MediWound Ltd. develops enzyme-based tissue regeneration products, leveraging US government contracts. Regular cash inflows are driven by NexoBrid sales in hospitals. Strong confidence among burn surgeons solidifies the brand's role as an innovator in the treatment of severe wounds.

MDWD MediWound, Ltd.: Market Cap to Future Revenue Ratio in the range 07/04/2022 - 11/14/2026

mediwound.com - analytical breakdowns and key metrics (MDWD)

- current price and projected stock value:
Stock Price MediWound|MDWD - Analyst Median Target
- market capitalization details:
Market Valuation MediWound Ltd|MDWD - Real Price to Acquire Entire Company
- business book valuation details:
Net Assets per Single Share MediWound Ltd.|MDWD - Total Stockholders' Equity|Market Cap to Net Assets Ratio mediwound.com|MDWD - Company Total Assets
- debt level and financial liquidity data:
Debt to Equity MediWound Ltd.|MDWD - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital MediWound|MDWD - Company Aggregate Debt|Debt to Book Value MediWound Ltd|MDWD - Company Long-Term Loans and Borrowings|Company Short-Term Debt MediWound Ltd.|Quick Liquidity Indicator mediwound.com
- business earnings and investment ratios data:
MDWD - Profit After Payment of Taxes|Projected Future Earnings MediWound Ltd.|MDWD - Price to Earnings Multiple|Projected Price to Earnings MediWound|MDWD - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MediWound Ltd|MDWD - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) MediWound Ltd.|MDWD - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months mediwound.com|MDWD - Net earnings per share growth this year|Earnings growth forecast for next year MediWound Ltd.
- revenue and sales details:
MDWD - Company Sales Volume|Company Future Sales Volume MediWound|MDWD - Market Cap to Sales Volume|Price-to-Projected Revenue Ratio MediWound Ltd
Fundamental company valuation:MediWound, Ltd. (MDWD)
Original product of mediwound.com

For the biopharmaceutical business of MediWound Ltd. (MDWD), this indicator serves as a gauge of market expectations regarding the monetization of future sales amid regulatory risks and raw material logistics vulnerabilities. By analyzing the company's modeled P/S, an investor determines the value of one dollar of expected revenue, where an upward trend confirms market confidence in the successful expansion of technologies, while a decline signals a revaluation of asset costs.

Key competitors

Forward P/S Multiple HCA (HCA Healthcare)|Market Cap to Expected Sales Ratio Tenet Healthcare Corp (THC)|FMS: Forward Price-to-Revenue Multiple|Solventum Health (SOLV) - Forward Price-to-Revenue Multiple|Encompass Health (EHC) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Universal Health Services, Inc. (UHS)|Forward Price-to-Revenue Multiple DVA|Forward P/S Multiple RadNet Inc|Price-to-Projected Revenue Ratio Option Care Health Inc (OPCH)|Surgery Partners Group - Market Cap to Projected Revenue|Forward P/S Multiple PINC (Premier, Inc.)|EYE: Market Cap to Projected Revenue|PGNY: Forward Price-to-Revenue Multiple|Forward Price to Sales ARDT (Ardent Health)|Select Medical Corp (SEM) - Price-to-Projected Revenue Ratio|ASTH (Astrana Corp) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple MD|USPH (US Physical Therapy Inc) - Price to Expected Revenue Ratio|Forward P/S Multiple PNTG|Organogenesis Holdings Inc. - Market Cap to Projected Revenue|Nutex Health Corp - Forward Price-to-Revenue Multiple|Market Cap to Expected Sales Ratio Auna Corp (AUNA)|SBC - Price-to-Projected Revenue Ratio|evolus.com (EOLS) - Forward Price-to-Revenue Multiple|CYH: Forward P/S Multiple|Market Cap to Projected Revenue SKIN|Forward Price-to-Revenue Multiple BTMD|Forward Price-to-Revenue Multiple The Joint (JYNT)|Forward P/S Multiple DCGO|p3hp.org - Market Cap to Projected Revenue|Gain Therapeutics - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio EUDA (EUDA Health Holdings)|BMGL - Price-to-Projected Revenue Ratio|Forward Price to Sales CLGN (CollPlant Biotechnologies)|CUPR: Forward P/S Multiple|Market Cap to Future Revenue Ratio concordmedical.com (CCM)|AMS (American Shared Hospital Services) - Forward P/S Multiple|Forward P/S Multiple MEDIROM Healthcare Group Inc.|Forward Price-to-Revenue Multiple ALBT (Avalon GloboCare)|Price to Expected Revenue Ratio DHAI|Price-to-Projected Revenue Ratio Longevity Health Holdings XAGE|NIVF - Forward Price-to-Revenue Multiple|ATI Physical Therapy Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio CareMax Inc.|Kindly MD Corp (KDLY) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue MODV|Forward Price-to-Revenue Multiple NVOS|SSY (SunLink Health Systems, Inc) - Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio IMAC Holdings (BACK)